Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Dynamic 11C-PiB PET Shows Cerebrospinal Fluid Flow Alterations in Alzheimer Disease and Multiple Sclerosis.

Schubert JJ, Veronese M, Marchitelli L, Bodini B, Tonietto M, Stankoff B, Brooks DJ, Bertoldo A, Edison P, Turkheimer FE.

J Nucl Med. 2019 Oct;60(10):1452-1460. doi: 10.2967/jnumed.118.223834. Epub 2019 Mar 8.

PMID:
30850505
2.

Covariance statistics and network analysis of brain PET imaging studies.

Veronese M, Moro L, Arcolin M, Dipasquale O, Rizzo G, Expert P, Khan W, Fisher PM, Svarer C, Bertoldo A, Howes O, Turkheimer FE.

Sci Rep. 2019 Feb 21;9(1):2496. doi: 10.1038/s41598-019-39005-8.

3.

Widespread microglial activation in multiple system atrophy.

Kübler D, Wächter T, Cabanel N, Su Z, Turkheimer FE, Dodel R, Brooks DJ, Oertel WH, Gerhard A.

Mov Disord. 2019 Apr;34(4):564-568. doi: 10.1002/mds.27620. Epub 2019 Feb 6.

4.

Conflicting emergences. Weak vs. strong emergence for the modelling of brain function.

Turkheimer FE, Hellyer P, Kehagia AA, Expert P, Lord LD, Vohryzek J, De Faria Dafflon J, Brammer M, Leech R.

Neurosci Biobehav Rev. 2019 Apr;99:3-10. doi: 10.1016/j.neubiorev.2019.01.023. Epub 2019 Jan 23. Review.

5.

Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [18F]DOPA PET and fMRI study.

Kim S, Jung WH, Howes OD, Veronese M, Turkheimer FE, Lee YS, Lee JS, Kim E, Kwon JS.

Psychol Med. 2018 Nov 21:1-10. doi: 10.1017/S0033291718003471. [Epub ahead of print]

PMID:
30460891
6.

Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies.

Marques TR, Ashok AH, Pillinger T, Veronese M, Turkheimer FE, Dazzan P, Sommer IEC, Howes OD.

Psychol Med. 2019 Oct;49(13):2186-2196. doi: 10.1017/S0033291718003057. Epub 2018 Oct 25.

7.

Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging.

Singh N, Veronese M, O'Doherty J, Sementa T, Bongarzone S, Cash D, Simmons C, Arcolin M, Marsden PK, Gee A, Turkheimer FE.

Nucl Med Biol. 2018 Nov;66:32-39. doi: 10.1016/j.nucmedbio.2018.08.005. Epub 2018 Aug 30.

8.

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.

Wilson H, Giordano B, Turkheimer FE, Chaudhuri KR, Politis M.

Neuroimage Clin. 2018 Mar 2;18:630-637. doi: 10.1016/j.nicl.2018.03.001. eCollection 2018.

9.

Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study.

Jauhar S, Veronese M, Nour MM, Rogdaki M, Hathway P, Turkheimer FE, Stone J, Egerton A, McGuire P, Kapur S, Howes OD.

Mol Psychiatry. 2019 Oct;24(10):1502-1512. doi: 10.1038/s41380-018-0042-4. Epub 2018 Apr 20.

10.

Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities.

Rizzo G, Veronese M, Tonietto M, Bodini B, Stankoff B, Wimberley C, Lavisse S, Bottlaender M, Bloomfield PS, Howes O, Zanotti-Fregonara P, Turkheimer FE, Bertoldo A.

J Cereb Blood Flow Metab. 2019 May;39(5):874-885. doi: 10.1177/0271678X17742004. Epub 2017 Nov 14.

PMID:
29135382
11.

Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors.

Bhattacharyya S, Egerton A, Kim E, Rosso L, Riano Barros D, Hammers A, Brammer M, Turkheimer FE, Howes OD, McGuire P.

Sci Rep. 2017 Nov 3;7(1):15025. doi: 10.1038/s41598-017-14203-4.

12.

From homeostasis to behavior: Balanced activity in an exploration of embodied dynamic environmental-neural interaction.

Hellyer PJ, Clopath C, Kehagia AA, Turkheimer FE, Leech R.

PLoS Comput Biol. 2017 Aug 24;13(8):e1005721. doi: 10.1371/journal.pcbi.1005721. eCollection 2017 Aug.

13.

Kinetic modelling of [11C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis.

Veronese M, Reis Marques T, Bloomfield PS, Rizzo G, Singh N, Jones D, Agushi E, Mosses D, Bertoldo A, Howes O, Roncaroli F, Turkheimer FE.

J Cereb Blood Flow Metab. 2018 Jul;38(7):1227-1242. doi: 10.1177/0271678X17712388. Epub 2017 Jun 5.

14.

Multimodal partial volume correction: Application to [11C]PIB PET/MRI myelin imaging in multiple sclerosis.

Grecchi E, Veronese M, Bodini B, García-Lorenzo D, Battaglini M, Stankoff B, Turkheimer FE.

J Cereb Blood Flow Metab. 2017 Dec;37(12):3803-3817. doi: 10.1177/0271678X17712183. Epub 2017 Jun 1. Erratum in: J Cereb Blood Flow Metab. 2018 Jan 1;38(6):1120. J Cereb Blood Flow Metab. 2018 Jan 1;38(6):119.

15.

Protein synthesis is associated with high-speed dynamics and broad-band stability of functional hubs in the brain.

Hellyer PJ, Barry EF, Pellizzon A, Veronese M, Rizzo G, Tonietto M, Schütze M, Brammer M, Aurélio Romano-Silva M, Bertoldo A, Turkheimer FE.

Neuroimage. 2017 Jul 15;155:209-216. doi: 10.1016/j.neuroimage.2017.04.062. Epub 2017 May 2.

16.

Test-retest reproducibility of quantitative binding measures of [11C]Ro15-4513, a PET ligand for GABAA receptors containing alpha5 subunits.

McGinnity CJ, Riaño Barros DA, Rosso L, Veronese M, Rizzo G, Bertoldo A, Hinz R, Turkheimer FE, Koepp MJ, Hammers A.

Neuroimage. 2017 May 15;152:270-282. doi: 10.1016/j.neuroimage.2016.12.038. Epub 2017 Mar 11.

17.

A Variational Bayesian inference method for parametric imaging of PET data.

Castellaro M, Rizzo G, Tonietto M, Veronese M, Turkheimer FE, Chappell MA, Bertoldo A.

Neuroimage. 2017 Apr 15;150:136-149. doi: 10.1016/j.neuroimage.2017.02.009. Epub 2017 Feb 14.

PMID:
28213113
18.

Spectral Analysis of Dynamic PET Studies: A Review of 20 Years of Method Developments and Applications.

Veronese M, Rizzo G, Bertoldo A, Turkheimer FE.

Comput Math Methods Med. 2016;2016:7187541. doi: 10.1155/2016/7187541. Epub 2016 Dec 5. Review.

19.

Corrigendum to "Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers" [Neurobiol. Dis. 83 (2015) 115-121].

Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P.

Neurobiol Dis. 2017 Feb;98:162. doi: 10.1016/j.nbd.2016.12.003. Epub 2016 Dec 8. No abstract available.

PMID:
27939917
20.

Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [11C]DASB PK-PD Study.

Kim E, Howes OD, Kim BH, Chon MW, Seo S, Turkheimer FE, Lee JS, Lee YS, Kwon JS.

Clin Pharmacokinet. 2017 Apr;56(4):371-381. doi: 10.1007/s40262-016-0444-x.

PMID:
27557550
21.

TSPO expression in brain tumours: is TSPO a target for brain tumour imaging?

Roncaroli F, Su Z, Herholz K, Gerhard A, Turkheimer FE.

Clin Transl Imaging. 2016;4:145-156. Epub 2016 Mar 22. Review.

22.

MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.

Rizzo G, Veronese M, Expert P, Turkheimer FE, Bertoldo A.

PLoS One. 2016 Feb 16;11(2):e0148744. doi: 10.1371/journal.pone.0148744. eCollection 2016.

23.

Measuring specific receptor binding of a PET radioligand in human brain without pharmacological blockade: The genomic plot.

Veronese M, Zanotti-Fregonara P, Rizzo G, Bertoldo A, Innis RB, Turkheimer FE.

Neuroimage. 2016 Apr 15;130:1-12. doi: 10.1016/j.neuroimage.2016.01.058. Epub 2016 Feb 2.

24.

Amyloid pathology and axonal injury after brain trauma.

Scott G, Ramlackhansingh AF, Edison P, Hellyer P, Cole J, Veronese M, Leech R, Greenwood RJ, Turkheimer FE, Gentleman SM, Heckemann RA, Matthews PM, Brooks DJ, Sharp DJ.

Neurology. 2016 Mar 1;86(9):821-8. doi: 10.1212/WNL.0000000000002413. Epub 2016 Feb 3.

25.

Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive.

Mouchlianitis E, Bloomfield MA, Law V, Beck K, Selvaraj S, Rasquinha N, Waldman A, Turkheimer FE, Egerton A, Stone J, Howes OD.

Schizophr Bull. 2016 May;42(3):744-52. doi: 10.1093/schbul/sbv151. Epub 2015 Dec 17.

26.

TSPO: functions and applications of a mitochondrial stress response pathway.

Campanella M, Turkheimer FE.

Biochem Soc Trans. 2015 Aug;43(4):593-4. doi: 10.1042/BST20150068. Epub 2015 Aug 3.

PMID:
26551698
27.

The methodology of TSPO imaging with positron emission tomography.

Turkheimer FE, Rizzo G, Bloomfield PS, Howes O, Zanotti-Fregonara P, Bertoldo A, Veronese M.

Biochem Soc Trans. 2015 Aug;43(4):586-92. doi: 10.1042/BST20150058. Epub 2015 Aug 3. Review.

28.

Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.

Kim E, Howes OD, Park JW, Kim SN, Shin SA, Kim BH, Turkheimer FE, Lee YS, Kwon JS.

Psychol Med. 2016 Jan;46(2):357-66. doi: 10.1017/S0033291715001865. Epub 2015 Oct 1.

PMID:
26423910
29.

The cortical thickness phenotype of individuals with DISC1 translocation resembles schizophrenia.

Doyle OM, Bois C, Thomson P, Romaniuk L, Whitcher B, Williams SC, Turkheimer FE, Stefansson H, McIntosh AM, Mehta MA, Lawrie SM.

J Clin Invest. 2015 Sep;125(9):3714-22. doi: 10.1172/JCI82636. Epub 2015 Aug 24.

30.

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers.

Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P.

Neurobiol Dis. 2015 Nov;83:115-21. doi: 10.1016/j.nbd.2015.08.011. Epub 2015 Aug 18.

PMID:
26297319
31.

Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies.

Grecchi E, O'Doherty J, Veronese M, Tsoumpas C, Cook GJ, Turkheimer FE.

J Nucl Med. 2015 Sep;56(9):1408-14. doi: 10.2967/jnumed.115.160598. Epub 2015 Jul 16.

32.

Quantification of [(11)C]PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography.

Veronese M, Bodini B, García-Lorenzo D, Battaglini M, Bongarzone S, Comtat C, Bottlaender M, Stankoff B, Turkheimer FE.

J Cereb Blood Flow Metab. 2015 Nov;35(11):1771-82. doi: 10.1038/jcbfm.2015.120. Epub 2015 Jun 10.

33.

The brain's code and its canonical computational motifs. From sensory cortex to the default mode network: A multi-scale model of brain function in health and disease.

Turkheimer FE, Leech R, Expert P, Lord LD, Vernon AC.

Neurosci Biobehav Rev. 2015 Aug;55:211-22. doi: 10.1016/j.neubiorev.2015.04.014. Epub 2015 May 5. Review.

PMID:
25956253
34.

The 18-kDa mitochondrial translocator protein in human gliomas: an 11C-(R)PK11195 PET imaging and neuropathology study.

Su Z, Roncaroli F, Durrenberger PF, Coope DJ, Karabatsou K, Hinz R, Thompson G, Turkheimer FE, Janczar K, Du Plessis D, Brodbelt A, Jackson A, Gerhard A, Herholz K.

J Nucl Med. 2015 Apr;56(4):512-7. doi: 10.2967/jnumed.114.151621. Epub 2015 Feb 26.

35.

Fractal analysis of MRI data for the characterization of patients with schizophrenia and bipolar disorder.

Squarcina L, De Luca A, Bellani M, Brambilla P, Turkheimer FE, Bertoldo A.

Phys Med Biol. 2015 Feb 21;60(4):1697-716. doi: 10.1088/0031-9155/60/4/1697. Epub 2015 Jan 29.

PMID:
25633275
36.

Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.

Giannetti P, Politis M, Su P, Turkheimer FE, Malik O, Keihaninejad S, Wu K, Waldman A, Reynolds R, Nicholas R, Piccini P.

Brain. 2015 Jan;138(Pt 1):110-9. doi: 10.1093/brain/awu331. Epub 2014 Nov 21.

37.

A multifractal approach to space-filling recovery for PET quantification.

Willaime JM, Aboagye EO, Tsoumpas C, Turkheimer FE.

Med Phys. 2014 Nov;41(11):112505. doi: 10.1118/1.4898122.

38.

The X-Linked Hypothesis of Brain Disorders: Can Gender Ratios Tell Us Anything About Cellular Etiology of Neurodegenerative and Psychiatric Diseases?

Turkheimer FE, Bodini B, Politis M, Pariante CM, Ciccarelli O, Yeo RA.

Neuroscientist. 2015 Dec;21(6):589-98. doi: 10.1177/1073858414545999. Epub 2014 Aug 8. Review.

PMID:
25106640
39.

Acute increases in synaptic GABA detectable in the living human brain: a [¹¹C]Ro15-4513 PET study.

Stokes PR, Myers JF, Kalk NJ, Watson BJ, Erritzoe D, Wilson SJ, Cunningham VJ, Riano Barros D, Hammers A, Turkheimer FE, Nutt DJ, Lingford-Hughes AR.

Neuroimage. 2014 Oct 1;99:158-65. doi: 10.1016/j.neuroimage.2014.05.035. Epub 2014 May 17.

PMID:
24844747
40.

Brain shaving: adaptive detection for brain PET data.

Grecchi E, Doyle OM, Bertoldo A, Pavese N, Turkheimer FE.

Phys Med Biol. 2014 May 21;59(10):2517-34. doi: 10.1088/0031-9155/59/10/2517. Epub 2014 Apr 28.

PMID:
24778363
41.

A graphical method to compare the in vivo binding potential of PET radioligands in the absence of a reference region: application to [¹¹C]PBR28 and [¹⁸F]PBR111 for TSPO imaging.

Guo Q, Owen DR, Rabiner EA, Turkheimer FE, Gunn RN.

J Cereb Blood Flow Metab. 2014 Jul;34(7):1162-8. doi: 10.1038/jcbfm.2014.65. Epub 2014 Apr 16.

42.

Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [¹¹C]MePPEP.

Riaño Barros DA, McGinnity CJ, Rosso L, Heckemann RA, Howes OD, Brooks DJ, Duncan JS, Turkheimer FE, Koepp MJ, Hammers A.

Neuroimage. 2014 Aug 15;97:151-62. doi: 10.1016/j.neuroimage.2014.04.020. Epub 2014 Apr 13.

43.

Kinetic modeling without accounting for the vascular component impairs the quantification of [(11)C]PBR28 brain PET data.

Rizzo G, Veronese M, Tonietto M, Zanotti-Fregonara P, Turkheimer FE, Bertoldo A.

J Cereb Blood Flow Metab. 2014 Jun;34(6):1060-9. doi: 10.1038/jcbfm.2014.55. Epub 2014 Mar 26.

44.

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.

Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P.

J Clin Invest. 2014 Mar;124(3):1340-9. doi: 10.1172/JCI71640. Epub 2014 Feb 17.

45.

The predictive power of brain mRNA mappings for in vivo protein density: a positron emission tomography correlation study.

Rizzo G, Veronese M, Heckemann RA, Selvaraj S, Howes OD, Hammers A, Turkheimer FE, Bertoldo A.

J Cereb Blood Flow Metab. 2014 May;34(5):827-35. doi: 10.1038/jcbfm.2014.21. Epub 2014 Feb 5.

46.

Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding.

Guo Q, Colasanti A, Owen DR, Onega M, Kamalakaran A, Bennacef I, Matthews PM, Rabiner EA, Turkheimer FE, Gunn RN.

J Nucl Med. 2013 Nov;54(11):1915-23. doi: 10.2967/jnumed.113.121020. Epub 2013 Sep 26.

47.

Reference region automatic extraction in dynamic [(11)C]PIB.

Ikoma Y, Edison P, Ramlackhansingh A, Brooks DJ, Turkheimer FE.

J Cereb Blood Flow Metab. 2013 Nov;33(11):1725-31. doi: 10.1038/jcbfm.2013.133. Epub 2013 Aug 7.

48.

Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET.

Watson BJ, Taylor LG, Reid AG, Wilson SJ, Stokes PR, Brooks DJ, Myers JF, Turkheimer FE, Nutt DJ, Lingford-Hughes AR.

Addict Biol. 2014 Nov;19(6):1032-40. doi: 10.1111/adb.12073. Epub 2013 Jul 5.

49.

Cerebral energy metabolism and the brain's functional network architecture: an integrative review.

Lord LD, Expert P, Huckins JF, Turkheimer FE.

J Cereb Blood Flow Metab. 2013 Sep;33(9):1347-54. doi: 10.1038/jcbfm.2013.94. Epub 2013 Jun 12. Review.

50.

SAKE: a new quantification tool for positron emission tomography studies.

Veronese M, Rizzo G, Turkheimer FE, Bertoldo A.

Comput Methods Programs Biomed. 2013 Jul;111(1):199-213. doi: 10.1016/j.cmpb.2013.03.016. Epub 2013 Apr 20.

PMID:
23611334

Supplemental Content

Loading ...
Support Center